$7.67
-0.01 (-0.13%)
Open$7.63
Previous Close$7.68
Day High$7.73
Day Low$7.62
52W High$14.21
52W Low$3.53
Volume—
Avg Volume11.2K
Market Cap72.14M
P/E Ratio—
EPS$-20.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+424.4% upside
Current
$7.67
$7.67
Target
$40.22
$40.22
$30.63
$40.22 avg
$46.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.05M | 8.81M | 7.55M |
| Net Income | 1.50M | 1.95M | 1.65M |
| Profit Margin | 16.6% | 22.2% | 21.9% |
| EBITDA | 2.36M | 2.47M | 1.95M |
| Free Cash Flow | 1.28M | 1.29M | 705.7K |
| Rev Growth | -8.9% | +8.5% | +16.9% |
| Debt/Equity | 0.33 | 0.32 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |